Thomas Reiser/LinkedIn
Dec 11, 2025, 23:36
Register for the ISTH Andexanet Research Recap
Thomas Reiser, Executive Director of the International Society on Thrombosis and Haemostasis (ISTH), posted on LinkedIn:
”How do researchers evaluate the effects of andexanet in healthy volunteers and patients with acute major bleeding on enoxaparin?
Register for the upcoming International Society on Thrombosis and Haemostasis (ISTH) RPTH Journal Research Recap on
December 18 (17:00 UTC) with author Thijs van Haaps and Moderator Lara Roberts.”
Stay updated with Hemostasis Today.
-
Apr 12, 2026, 22:12Maciej Banach: The ‘Metastatic’ Cardiovascular Threat We Can No Longer Ignore
-
Apr 12, 2026, 21:52Umar Jawed: The Most Dangerous Anti-D Result Is Not the Highest One – It’s the One You Underestimate Early
-
Apr 12, 2026, 21:37Demosthenes Panagiotakos: Hellenic Atherosclerosis Society Calls for Papers on Innovative Strategies in Atherosclerotic Plaque Management
-
Apr 12, 2026, 21:24Heghine Khachatryan: Diagnosing PNH in Resource-Limited Settings
-
Apr 12, 2026, 21:15Katariina Öörni: Role of Cholesterol Absorption Efficiency in Atherosclerosis
-
Apr 12, 2026, 17:34Caitlin Raymond: Granulocyte Transfusions for the Overworked Fellow
-
Apr 12, 2026, 17:33Augustina Isioma Ikusemoro: ABO Typing Is Not the Same in Infants and Adults
-
Apr 12, 2026, 17:32Bastu Odoka: Same Blood Group Does Not Guarantee Compatibility
-
Apr 12, 2026, 17:31Jack Hadfield: SARS-CoV-2–Associated Lasting Mitochondrial Injury in Cardiomyocytes